NCT07748221

Brief Summary

ONCO-MinD is a multicentre, cross-sectional, non-interventional mixed-method study aimed at investigating healthcare providers' attitudes towards oncology patients with mental disorders in Italian cancer centres. The study will assess levels of mental health-related stigma among healthcare professionals and explore factors associated with these attitudes, including professional background, clinical setting, experience, and previous exposure to mental health conditions. Quantitative survey data collected using the Italian version of the Opening Minds Scale for Health Care Providers (OMS-HC) will be integrated with qualitative findings from semi-structured interviews to provide a comprehensive understanding of how stigma may influence clinical relationships, decision-making processes, and equity of cancer care.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
17mo left

Started Nov 2026

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 5, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2028

Last Updated

September 16, 2026

Status Verified

September 1, 2026

Enrollment Period

1.2 years

First QC Date

July 23, 2026

Last Update Submit

September 11, 2026

Conditions

CancerPsychiatric ComorbidityStigma of Mental Illness

Keywords

oncologycancermental healthstigmapsychiatric comorbidityoncology healthcare professionals

Outcome Measures

Primary Outcomes (1)

  • Mental health-related stigma among oncology healthcare professionals

    Level of stigma towards people with mental disorders measured using the Italian version of the Opening Minds Scale for Health Care Providers (OMS-HC). The total score ranges from 15 to 75, with higher scores indicating greater stigma and lower scores indicating more positive attitudes towards people with mental disorders.

    At survey completion (up to 3 months)

Secondary Outcomes (3)

  • Factors Associated With OMS-HC Scores

    Up to 3 months

  • Healthcare professionals' experiences and perceptions regarding oncology patients with mental disorders

    Up to 9 months

  • Integrated mixed-method understanding of stigma towards oncology patients with mental disorders

    Up to 13 months

Study Arms (1)

Oncology Healthcare Professionals

Physicians, nurses, psychologists, radiation therapy technologists, and healthcare assistants working in participating oncology centres.

Other: OMS-HC Questionnaire and Semi-Structured Interviews

Interventions

OMS-HC Questionnaire and Semi-Structured InterviewsOTHER

Participants complete an anonymous questionnaire and, where selected, participate in a semi-structured interview for research data collection purposes. No clinical or behavioural intervention is administered.

Oncology Healthcare Professionals

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of healthcare professionals working in oncology settings at participating Italian cancer centres. Eligible participants include physicians, nurses, psychologists, radiation therapy technologists, and healthcare assistants directly involved in the care of oncology patients. Participants will be recruited through exhaustive sampling across participating institutions and invited to complete an anonymous survey. A purposive sample of survey participants may subsequently be invited to participate in semi-structured interviews as part of the qualitative phase of the study.

You may qualify if:

  • Healthcare professionals working in participating oncology centres.
  • Physicians, nurses, psychologists, radiation therapy technologists, and healthcare assistants.
  • Direct involvement in the clinical care of oncology patients.
  • Employed at one of the participating study sites at the time of enrolment.
  • Able to understand the study information and provide informed consent.
  • Willing to participate in the study.
  • For the qualitative phase, a purposive sample of participants will be selected from survey respondents who agree to be contacted for a semi-structured interview.

You may not qualify if:

  • Refusal to participate or failure to provide informed consent.
  • Students in training.
  • Healthcare personnel working in services with very limited patient contact and without direct responsibility for oncology patient care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Centro Riferimento Oncologico CRO IRCCS

Aviano, 33081, Italy

Location

Istituto Tumori IRCCS Giovanni Paolo II

Bari, 70124, Italy

Location

The Padua, Castelfranco Veneto, and Schiavonia campuses of the Veneto Institute of Oncology (IOV-IRCCS).

Padova, 35128, Italy

Location

Related Publications (9)

  • Destrebecq A, Ferrara P, Frattini L, Pittella F, Rossano G, Striano G, Terzoni S, Gambini O. The Italian Version of the Opening Minds Stigma Scale for Healthcare Providers: Validation and Study on a Sample of Bachelor Students. Community Ment Health J. 2018 Jan;54(1):66-72. doi: 10.1007/s10597-017-0149-0. Epub 2017 Jun 24.

    PMID: 28647819RESULT

  • Pasere E, O'Hara D, Ballard E, Kilgour C, Holland L. A narrative review of medical and surgical nurses' attitudes and perceptions when caring for patients with a secondary diagnosis of mental illness. Nurse Educ Today. 2025 Aug;151:106684. doi: 10.1016/j.nedt.2025.106684. Epub 2025 Mar 20.

    PMID: 40168912RESULT

  • Kisely S, Sadek J, MacKenzie A, Lawrence D, Campbell LA. Excess cancer mortality in psychiatric patients. Can J Psychiatry. 2008 Nov;53(11):753-61. doi: 10.1177/070674370805301107.

    PMID: 19087469RESULT

  • Ivankova, N. V., Creswell, J. W., & Stick, S. L. (2006). Using mixed-methods sequential explanatory design: From theory to practice. Field methods, 18(1),

    RESULT

  • Giandinoto JA, Stephenson J, Edward KL. General hospital health professionals' attitudes and perceived dangerousness towards patients with comorbid mental and physical health conditions: Systematic review and meta-analysis. Int J Ment Health Nurs. 2018 Jun;27(3):942-955. doi: 10.1111/inm.12433. Epub 2018 Feb 5.

    PMID: 29399940RESULT

  • Firth J, Siddiqi N, Koyanagi A, Siskind D, Rosenbaum S, Galletly C, Allan S, Caneo C, Carney R, Carvalho AF, Chatterton ML, Correll CU, Curtis J, Gaughran F, Heald A, Hoare E, Jackson SE, Kisely S, Lovell K, Maj M, McGorry PD, Mihalopoulos C, Myles H, O'Donoghue B, Pillinger T, Sarris J, Schuch FB, Shiers D, Smith L, Solmi M, Suetani S, Taylor J, Teasdale SB, Thornicroft G, Torous J, Usherwood T, Vancampfort D, Veronese N, Ward PB, Yung AR, Killackey E, Stubbs B. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry. 2019 Aug;6(8):675-712. doi: 10.1016/S2215-0366(19)30132-4. Epub 2019 Jul 16. No abstract available.

    PMID: 31324560RESULT

  • Elliott K, Haworth E, Bolnykh I, McAllister-Williams RH, Greystoke A, Todd A, Sharp L. Breast cancer patients with a pre-existing mental illness are less likely to receive guideline-recommended cancer treatment: A systematic review and meta-analysis. Breast. 2025 Feb;79:103855. doi: 10.1016/j.breast.2024.103855. Epub 2024 Dec 7.

    PMID: 39708443RESULT

  • Creswell JW, Inoue M. A process for conducting mixed methods data analysis. J Gen Fam Med. 2024 Oct 3;26(1):4-11. doi: 10.1002/jgf2.736. eCollection 2025 Jan.

    PMID: 39776872RESULT

  • Charlesworth L, Fegan C, Ashmore R. How does severe mental illness impact on cancer outcomes in individuals with severe mental illness and cancer? A scoping review of the literature. J Med Imaging Radiat Sci. 2023 Jun;54(2S):S104-S114. doi: 10.1016/j.jmir.2023.01.007. Epub 2023 Feb 15.

    PMID: 36804013RESULT

Related Links

MeSH Terms

Conditions

NeoplasmsPsychological Well-BeingSocial Stigma

Condition Hierarchy (Ancestors)

Personal SatisfactionBehaviorSocial Behavior

Study Officials

  • Carlo Alberto Camuccio, MSN; MSC

    Istituto Oncologico Veneto - IOV IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Carlo Alberto Camuccio, MSN; MSC

CONTACT

+39 3336173150alberto.camuccio@iov.veneto.it

Angela Grassi, PhD

CONTACT

+39 498215527angela.grassi@iov.veneto.it

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2026

First Posted

August 5, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

March 31, 2028

Last Updated

September 16, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Due to the nature of the study and the need to protect participant confidentiality, individual participant data will not be shared. Results will be reported only in aggregated and anonymised form.

Locations

IT(3)